Latest research report on “Anti-tumor Drug Market” now available at high quality database of ReportsnReports.com with market size, share, trends, competitive and statistical analysis. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample Research Copy @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5560608
Anti-tumor drugs are for the treatment of cancer diseases. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of the tumor. The invention and application of advanced technologies such as large-scale rapid screening, combinatorial chemistry and genetic engineering have accelerated the process of drug development. The research and development of anti-tumor drugs have been into a new era.
This report contains market size and forecasts of Anti-tumor Drug in Global, including the following market information:
Global Anti-tumor Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anti-tumor Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cytotoxic Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti-tumor Drug include Roche, Novartis, Celgene, Bristol-Myers Squibb, Amgen, Johnson & Johnson, Pfizer, Takeda and Eli Lilly, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-tumor Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-tumor Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anti-tumor Drug Market Segment Percentages, by Type, 2021 (%)
– Cytotoxic Drugs
– Non-cytotoxic Drugs
Global Anti-tumor Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anti-tumor Drug Market Segment Percentages, by Application, 2021 (%)
– Alkylating Agents
– Anti-Metabolism Drugs
– Platinum Antineoplastic Agents
– Anthracycline Antitumor Drugs
– Microtubule Stabilizer
– Endocrine Therapy Drugs
– Immunotherapy Drugs
– Gene Therapy Drugs
– Targeted Antineoplastic Drugs
Global Anti-tumor Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anti-tumor Drug Market Segment Percentages, By Region and Country, 2021 (%)
– North America
– – US
– – Canada
– – Mexico
– – Germany
– – France
– – U.K.
– – Italy
– – Russia
– – Nordic Countries
– – Benelux
– – Rest of Europe
– – China
– – Japan
– – South Korea
– – Southeast Asia
– – India
– – Rest of Asia
– South America
– – Brazil
– – Argentina
– – Rest of South America
– Middle East & Africa
– – Turkey
– – Israel
– – Saudi Arabia
– – UAE
– – Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Anti-tumor Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anti-tumor Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
– Bristol-Myers Squibb
– Johnson & Johnson
– Eli Lilly
– Merck & Co
– Biogen Idec
More information about Discount offers (25% or More) @ https://www.reportsnreports.com/contacts/discount.aspx?name=5560608
About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
We provide 24/7 online and offline support to our customers.
E-mail: [email protected]
Phone: +1 888 391 5441